Intuitive Surgical (NASDAQ:ISRG) Director Sells $4,000,000.00 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Gary Guthart sold 10,000 shares of the business’s stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total transaction of $4,000,000.00. Following the transaction, the director owned 1,245,679 shares of the company’s stock, valued at approximately $498,271,600. The trade was a 0.80% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Intuitive Surgical Stock Up 0.3%

Intuitive Surgical stock traded up $1.07 during midday trading on Wednesday, reaching $402.30. The company’s stock had a trading volume of 2,165,107 shares, compared to its average volume of 2,467,366. The company has a market cap of $142.12 billion, a P/E ratio of 46.08, a P/E/G ratio of 2.84 and a beta of 1.46. The business has a 50-day simple moving average of $392.47 and a 200-day simple moving average of $443.35. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The business had revenue of $2.89 billion during the quarter, compared to analysts’ expectations of $2.83 billion. During the same period in the prior year, the firm posted $1.81 EPS. The business’s quarterly revenue was up 18.4% compared to the same quarter last year. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of research analyst reports. JPMorgan Chase & Co. cut their price objective on shares of Intuitive Surgical from $550.00 to $450.00 and set an “overweight” rating on the stock in a report on Friday, July 17th. Jefferies Financial Group lowered their target price on shares of Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating for the company in a report on Wednesday, April 22nd. BTIG Research dropped their target price on shares of Intuitive Surgical from $512.00 to $469.00 and set a “buy” rating on the stock in a research report on Friday, July 17th. Evercore set a $430.00 price target on shares of Intuitive Surgical in a research note on Monday, July 6th. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on shares of Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating for the company in a research report on Tuesday, June 2nd. Twenty-two equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $508.68.

Institutional Trading of Intuitive Surgical

A number of large investors have recently bought and sold shares of ISRG. Main Street Group LTD acquired a new position in Intuitive Surgical in the first quarter valued at $30,000. Laurel Wealth Advisors LLC acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth about $31,000. Vermillion Wealth Management Inc. grew its holdings in shares of Intuitive Surgical by 58.1% during the first quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock worth $31,000 after buying an additional 25 shares during the last quarter. Turning Point Benefit Group Inc. grew its holdings in shares of Intuitive Surgical by 833.3% during the fourth quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock worth $32,000 after buying an additional 50 shares during the last quarter. Finally, Motiv8 Investments LLC acquired a new position in Intuitive Surgical in the 4th quarter valued at about $34,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Oppenheimer upgraded ISRG to Outperform from Perform and set a $500 price target. The firm said Intuitive Surgical’s strategy of “crowding out competitors” should help protect da Vinci’s market position, as Medtronic’s Hugo and Intuitive’s Ottava are not viewed as significant near-term threats. Oppenheimer upgrades Intuitive Surgical
• Positive Sentiment: Bernstein reiterated a Buy rating and maintained a $685 price target, citing progress on Intuitive’s next-generation gastrointestinal surgery platform as a potential source of longer-term growth. Bernstein maintains Buy rating
• Positive Sentiment: The ENCOMPASS post-market clinical trial is highlighting the potential for robotic-assisted lung biopsy procedures, supporting broader applications for Intuitive’s technology and possible future utilization growth. ENCOMPASS trial update
• Neutral Sentiment: Intuitive’s latest quarter was strong, with revenue up 18.4% year over year to $2.89 billion and EPS of $2.80 versus the $2.48 consensus estimate. However, the stock’s premium valuation—about 46 times earnings—leaves less room for execution disappointments.
• Negative Sentiment: Investors remain concerned about slowing domestic procedure growth, which helped pressure the stock despite the earnings beat. Recent director and executive sales were executed under pre-arranged Rule 10b5-1 plans, limiting their value as bearish signals but potentially weighing modestly on sentiment.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.